Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 4
Review
Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
20,065 | Dovepress* | 20,065+ | 1,673 | 21,738 | |
Totals | 20,065 | 1,673 | 21,738 | ||
*Since 18 September 2014 +Since July 2016 |
View citations on Google Scholar